Huvepharma® is a privately owned, fast-growing global pharmaceutical company with a focus on developing, manufacturing, and marketing animal health and nutrition products.
Large, modern fermentation plants provide capacity for producing major molecules, purification and downstream processing as well as having extensive R&D, quality assurance and packaged goods facilities.
As of today, Huvepharma sells its own products in more than 100 countries with production facilities spread across the world. There are two production sites in France, a chemical synthesis plant in Italy, three production facilities for biotechnology and vaccines in Bulgaria, and six sites in the USA producing vaccines and veterinary medicines.
We place a strong emphasis on addressing customer requirements which we believe can only be achieved through close partnerships. This is why Huvepharma employs highly skilled individuals with extensive experience of the poultry industry coupled with a deep understanding and knowledge of local markets.
Our key strengths:
• Fermentation specialists with more than 70 years’ experience
• In-house capabilities for the complete production cycle; from strain to shelf
• Experts in poultry nutrition
• Extensive product portfolio including coccidiostats, veterinary products, enzymes, feed additives and hygiene products
• EU producer with a global network of offices and representatives
• Customer focused
Moreover, the team is dedicated to supplying a range of complementary services to shape livestock solutions.
Recently, we have invested in several renewable energy installations at our production sites in Bulgaria to support our commitment to carbon-neutral manufacturing by 2030.
For more information, visit
https://www.huvepharma.com/
